Mind + Muscle

technical minds + legal muscle

Bracket

dig deep

Strike Two – FDA Rejects Amgen’s Certification Petition for Biosimilar Applicants

  • 03.27.15
  • Paul A. Calvo, Ph.D.
  • Sterne, Kessler, Goldstein & Fox

In parallel with the district court case where Amgen is asserting that Sandoz has not complied with the BPCIA because they have not provided Amgen with a copy of their biosimilar application, in October 2014 Amgen filed a Citizens Petition requesting FDA require such disclosure. On March 25, 2015 FDA denied Amgen’s Petition.

In this alert, Paul A. Calvo, Ph.D. explains FDA's stance as stated in its denial of Amgen's Petition. 

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar
X

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.